CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 21 - 30 of 867
Study Number Lead Group Study Title CIRB Study Status
A031803 Alliance Phase II Trial of Intravesical Gemcitabine and MK-3475 (pembrolizumab) in the Treatment of Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Adult CIRB - Late Phase Emphasis Available to Open
A031901 Alliance Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: A Randomized Phase 3 Non-Inferiority Trial Adult CIRB - Late Phase Emphasis Available to Open
A071601 Alliance Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas Adult CIRB - Late Phase Emphasis Available to Open
A061402 Alliance Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment with Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid After Definite Radiation Therapy Adult CIRB - Late Phase Emphasis Available to Open
A221505 Alliance RT Charm: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction Cancer Prevention and Control CIRB Available to Open
A051901 Alliance Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (NIVO-MR2) Induction Followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma Adult CIRB - Early Phase Emphasis Available to Open
A211601 Alliance Evaluation of Mammographic Breast Density Effect of Aspirin: A companion study to Alliance Study A011502 Cancer Prevention and Control CIRB Available to Open
A021502 Alliance Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair (ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer) Adult CIRB - Late Phase Emphasis Available to Open
A091603 Alliance A Randomized Phase II Trial of Adjuvant Nivolumab or Expectant Observation Following Neoadjuvant Ipilimumab Plus Nivolumab and Surgical Resection of High-Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma Adult CIRB - Late Phase Emphasis Completed
A091404 Alliance A Phase II Study of Enzalutamide (NSC# 766085) for Patients with Androgen Receptor Positive Salivary Cancers Adult CIRB - Late Phase Emphasis Available to Open
Displaying 21 - 30 of 867